Oculis Holding AGOCS
13F holders, Q1 2024 (March 31)9holders
$12.05avg. 13F price*
At the end of Q1 2024, 9 institutions reported holding Oculis Holding AG (OCS) in their 13F filings. The largest holders were Pivotal bioVenture Partners Investment Advisor LLC ($19.2M), Aberdeen Group plc ($14.8M) and Nan Fung Group Holdings Ltd ($5.3M).
- Company
- Oculis Holding AG
- CUSIP
- H5870P102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $193K |
| Exits | 1 | $11K |
Ownership 9 holders
| Pivotal bioVenture Partners Investment Advisor LLC | 12.36% | Reduce -15.5% | 1,595,918 | $19.2M |
| Aberdeen Group plc | 0.03% | Reduce -15.5% | 1,228,042 | $14.8M |
| Nan Fung Group Holdings Ltd | 4.87% | Reduce -15.9% | 436,378 | $5.3M |
| Compagnie Lombard Odier SCmA | 0.02% | No change | 95,750 | $1.2M |
| Bank of America Corp. | 0.00% | Add +17.5% | 19,894 | $240K |
| Geode Capital Management, LLC | 0.00% | New | 14,944 | $180K |
| UBS Group AG | 0.00% | New | 1,097 | $13K |
| Dupont Capital Management Corp. | 0.00% | No change | 4 | $48 |
| JPMorgan Chase & Co. | 0.00% | New | 1 | $12 |
"% of holder's portfolio" is OCS's weight in each manager's 13F, not the share of Oculis Holding AG the manager owns.